Farfetch (NYSE: FTCH) shares are trading higher after the company reported better-than-expected Q1 results, with EPS and sales beating consensus estimates.
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) ("ImmunoPrecise" or "IPA" or the "Company") an AI-driven biotherapeutic research and technology company today announced a research collaboration
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic areas,